MagicTouch PTA Sirolimus-Coated Balloon for Femoropopliteal and Below-the-Knee Disease: 3-Year Outcomes of the XTOSI Trial
- 3 April 2024
- journal article
- research article
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 106, 8-15
Abstract
No abstract availableKeywords
Funding Information
- Concept Medical
This publication has 11 references indexed in Scilit:
- 12-Months Results From the PRESTIGE Study Using Sirolimus Drug-Eluting Balloons in the Treatment of Complex BTK Tibial Atherosclerotic Lesions in CLTI PatientsCardiovascular Revascularization Medicine, 2022
- Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in SingaporeSingapore Medical Journal, 2022
- MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 MonthsJournal of Endovascular Therapy, 2021
- High-pressure, non compliant balloon angioplasty for long and calcified infrapopliteal and inframalleolar lesions is feasibleInternational Angiology, 2020
- Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal LesionsJournal of Endovascular Therapy, 2020
- Amputation Rates, Mortality, and Pre-operative Comorbidities in Patients Revascularised for Intermittent Claudication or Critical Limb Ischaemia: A Population Based StudyEuropean Journal of Vascular and Endovascular Surgery, 2017
- A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery DiseaseJACC, 2007
- Sirolimus and Paclitaxel on Polymer-Based Drug-Eluting StentsJACC, 2006
- Sirolimus-Eluting Stents vs Paclitaxel-Eluting Stents in Patients With Coronary Artery DiseaseJAMA, 2005
- Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent RestenosisJAMA, 2005